Difficulty of picture and word recognition was manipulated to test the hypothesis that schizophrenics have adequate recognition memories and to determine whether overinclusion is related to a good visual recognition memory. Good and poor premorbid, acute and chronic schizophrenics were compared to nonpsychotic psychiatric patients and to hospital aides. Both Payne's Object Classification Test and Goldstein-Scheerer's Object Sorting Test were given to all the patients, but only the former differentiated among the diagnostic subgroups and was related to good picture memory. When the measures of overinclusion, chronicity, premorbidity and intelligence were used as independent variables in a multiple regression, only Payne NonA predicted success on the picture task. Good premorbid schizophrenics recognized pictures as well as normals and nonpsychotics, but poor premorbids' picture memory was significantly worse. No experimental variable predicted word performance in a multiple regression, and good premorbids did not differ from poor premorbids on their word recognition. The authors favored the interpretation that the pattern of performance of overinclusive schizophrenics reflects their tendency to scan broadly both important and unimportant features of stimuli.
The merit of increasing the involvement of staff and patients of residential treatment programs in decision-making has been discussed by numerous writers, but few studies have provided extensive measurement of this concept. The authors have developed a twenty-four-item scale that assesses in detail the nature and extent of participation by staff and patients in decisions about treatment planning and routine patient care.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.